103 related articles for article (PubMed ID: 22884939)
1. Metabolomic profiling rationalized pyruvate efficacy in cybrid cells harboring MELAS mitochondrial DNA mutations.
Kami K; Fujita Y; Igarashi S; Koike S; Sugawara S; Ikeda S; Sato N; Ito M; Tanaka M; Tomita M; Soga T
Mitochondrion; 2012 Nov; 12(6):644-53. PubMed ID: 22884939
[TBL] [Abstract][Full Text] [Related]
2. [MELAS (mitochondrial myopathy, encephalopathy lactic acidosis, and stroke-like episodes): clinical features and mitochondrial DNA mutations].
Goto Y
Nihon Rinsho; 1993 Sep; 51(9):2373-8. PubMed ID: 8411715
[TBL] [Abstract][Full Text] [Related]
3. Treatment options for mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome.
Santa KM
Pharmacotherapy; 2010 Nov; 30(11):1179-96. PubMed ID: 20973690
[TBL] [Abstract][Full Text] [Related]
4. Activation of the mitochondrial protein quality control system and actin cytoskeletal alterations in cells harbouring the MELAS mitochondrial DNA mutation.
Felk S; Ohrt S; Kussmaul L; Storch A; Gillardon F
J Neurol Sci; 2010 Aug; 295(1-2):46-52. PubMed ID: 20570288
[TBL] [Abstract][Full Text] [Related]
5. CHOP (C/EBP homologous protein) and ASNS (asparagine synthetase) induction in cybrid cells harboring MELAS and NARP mitochondrial DNA mutations.
Fujita Y; Ito M; Nozawa Y; Yoneda M; Oshida Y; Tanaka M
Mitochondrion; 2007; 7(1-2):80-8. PubMed ID: 17276738
[TBL] [Abstract][Full Text] [Related]
6. Radiolabeled Cu-ATSM as a novel indicator of overreduced intracellular state due to mitochondrial dysfunction: studies with mitochondrial DNA-less ρ0 cells and cybrids carrying MELAS mitochondrial DNA mutation.
Yoshii Y; Yoneda M; Ikawa M; Furukawa T; Kiyono Y; Mori T; Yoshii H; Oyama N; Okazawa H; Saga T; Fujibayashi Y
Nucl Med Biol; 2012 Feb; 39(2):177-85. PubMed ID: 22033022
[TBL] [Abstract][Full Text] [Related]
7. [MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes)].
Goto Y
Ryoikibetsu Shokogun Shirizu; 2001; (36):146-9. PubMed ID: 11596349
[No Abstract] [Full Text] [Related]
8. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome.
Sproule DM; Kaufmann P
Ann N Y Acad Sci; 2008 Oct; 1142():133-58. PubMed ID: 18990125
[TBL] [Abstract][Full Text] [Related]
9. ["MELAS" (A3243G) mutation of mitochondrial DNA: a study of the relationships between the clinical phenotype in 19 patients and morphological and molecular data].
Laforêt P; Ziegler F; Sternberg D; Rouche A; Frachon P; Fardeau M; Eymard B; Lombès A
Rev Neurol (Paris); 2000 Dec; 156(12):1136-47. PubMed ID: 11139730
[TBL] [Abstract][Full Text] [Related]
10. Increased mitochondrial DNA in blood vessels and ragged-red fibers in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS).
Tokunaga M; Mita S; Sakuta R; Nonaka I; Araki S
Ann Neurol; 1993 Mar; 33(3):275-80. PubMed ID: 7684581
[TBL] [Abstract][Full Text] [Related]
11. Functional mitochondrial heterogeneity in heteroplasmic cells carrying the mitochondrial DNA mutation associated with the MELAS syndrome (mitochondrial encephalopathy, lactic acidosis, and strokelike episodes).
Bakker A; Barthélémy C; Frachon P; Chateau D; Sternberg D; Mazat JP; Lombès A
Pediatr Res; 2000 Aug; 48(2):143-50. PubMed ID: 10926287
[TBL] [Abstract][Full Text] [Related]
12. GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases.
Fujita Y; Ito M; Kojima T; Yatsuga S; Koga Y; Tanaka M
Mitochondrion; 2015 Jan; 20():34-42. PubMed ID: 25446397
[TBL] [Abstract][Full Text] [Related]
13. Loss of mutant mitochondrial DNA harboring the MELAS A3243G mutation in human cybrid cells after cell-cell fusion with normal tissue-derived fibroblast cells.
Yano T; Tanaka M; Fukuda N; Ueda T; Nagase H
Int J Mol Med; 2010 Jan; 25(1):153-8. PubMed ID: 19956914
[TBL] [Abstract][Full Text] [Related]
14. β-Lapachone attenuates mitochondrial dysfunction in MELAS cybrid cells.
Jeong MH; Kim JH; Seo KS; Kwak TH; Park WJ
Biochem Biophys Res Commun; 2014 Nov; 454(3):417-22. PubMed ID: 25451262
[TBL] [Abstract][Full Text] [Related]
15. Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human mitochondrial disease.
Kirino Y; Goto Y; Campos Y; Arenas J; Suzuki T
Proc Natl Acad Sci U S A; 2005 May; 102(20):7127-32. PubMed ID: 15870203
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS.
Santorelli FM; Tanji K; Kulikova R; Shanske S; Vilarinho L; Hays AP; DiMauro S
Biochem Biophys Res Commun; 1997 Sep; 238(2):326-8. PubMed ID: 9299505
[TBL] [Abstract][Full Text] [Related]
17. Wolff-Parkinson-White syndrome in Patients With MELAS.
Sproule DM; Kaufmann P; Engelstad K; Starc TJ; Hordof AJ; De Vivo DC
Arch Neurol; 2007 Nov; 64(11):1625-7. PubMed ID: 17998445
[TBL] [Abstract][Full Text] [Related]
18. An infant with a mitochondrial A3243G mutation demonstrating the MELAS phenotype.
Kanaumi T; Hirose S; Goto Y; Naitou E; Mitsudome A
Pediatr Neurol; 2006 Mar; 34(3):235-8. PubMed ID: 16504796
[TBL] [Abstract][Full Text] [Related]
19. Adult-onset of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome presenting as acute meningoencephalitis: a case report.
Hsu YC; Yang FC; Perng CL; Tso AC; Wong LJ; Hsu CH
J Emerg Med; 2012 Sep; 43(3):e163-6. PubMed ID: 20036095
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of L-arginine for stroke-like episode in MELAS.
Kubota M; Sakakihara Y; Mori M; Yamagata T; Momoi-Yoshida M
Brain Dev; 2004 Oct; 26(7):481-3; discussion 480. PubMed ID: 15351086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
